(19)
(11) EP 4 203 987 A2

(12)

(88) Date of publication A3:
14.04.2022

(43) Date of publication:
05.07.2023 Bulletin 2023/27

(21) Application number: 21862665.3

(22) Date of filing: 25.08.2021
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
A61P 29/00(2006.01)
A61K 38/17(2006.01)
A61P 3/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A01K 2217/075; A01K 2227/105; A01K 2267/0368; A01K 2267/0306; A61K 9/0048; A61K 38/1709
(86) International application number:
PCT/US2021/047569
(87) International publication number:
WO 2022/046919 (03.03.2022 Gazette 2022/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.08.2020 US 202063070145 P

(71) Applicant: The Regents of the University of California
Oakland, CA 94607 (US)

(72) Inventors:
  • MILLER, Yury
    La Jolla, California 92093 (US)
  • CHOI, Soo-Ho
    La Jolla, California 92093 (US)
  • JU, Wonkyu
    La Jolla, California 92093 (US)

(74) Representative: Ghirardi, Valeria et al
De Simone & Partners S.r.l. Via Vincenzo Bellini, 20
00198 Roma
00198 Roma (IT)

   


(54) COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR NEUROINFLAMMATION